Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Boeri

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Pharmacoeconomics|June 6, 2018
Comparing the Relative Importance of Attributes of Metastatic Renal Cell Carcinoma Treatments to Patients and Physicians in the United States: A Discrete-Choice ExperimentJuan Marcos González, Justin Doan, David J Gebben, et al.
Journal of Health Economics|December 12, 2012
The role of regret minimisation in lifestyle choices affecting the risk of coronary heart diseaseMarco Boeri, Alberto Longo, José M Grisolía, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 2, 2023
A discrete choice experiment to quantify the influence of trial features on the decision to participate in cystic fibrosis trialsRebecca Dobra, Jane Davies, Stuart Elborn, et al.
Future Oncology (London, England)|September 28, 2021
CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma: physician preferences trading off benefits, risks and time to infusionMarco Boeri, Anna G Purdum, Jessie Sutphin, et al.
Environmental & Resource Economics|July 18, 2025
A Stated Preference Study to Explore Market-Based Instruments to Reduce Car UsageChristopher Tate, Alberto Longo, Marco Boeri, et al.
Expert Review of Vaccines|September 26, 2022
Travelers' preferences for tick-borne encephalitis vaccinationChristine Poulos, Marco Boeri, Joshua Coulter, et al.
The Journal of Dermatological Treatment|October 7, 2020
Quantifying patient preferences for systemic atopic dermatitis treatments using a discrete-choice experimentMarco Boeri, Jessie Sutphin, Brett Hauber, et al.
BMJ Open|March 3, 2021
Discrete choice experiment (DCE) to quantify the influence of trial features on the decision to participate in cystic fibrosis (CF) clinical trialsRebecca Anne Dobra, Marco Boeri, Stuart Elborn, et al.
Patient Preference and Adherence|August 3, 2019
From drug-delivery device to disease management tool: a study of preferences for enhanced features in next-generation self-injection devicesMarco Boeri, Boglarka Szegvari, Brett Hauber, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 4, 2018
Physician-Specific Maximum Acceptable Risk in Personalized Medicine: Implications for Medical Decision MakingMarco Boeri, Alan J McMichael, Joseph P M Kane, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Pharmacoeconomics|June 6, 2018
Comparing the Relative Importance of Attributes of Metastatic Renal Cell Carcinoma Treatments to Patients and Physicians in the United States: A Discrete-Choice ExperimentJuan Marcos González, Justin Doan, David J Gebben, et al.
Journal of Health Economics|December 12, 2012
The role of regret minimisation in lifestyle choices affecting the risk of coronary heart diseaseMarco Boeri, Alberto Longo, José M Grisolía, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 2, 2023
A discrete choice experiment to quantify the influence of trial features on the decision to participate in cystic fibrosis trialsRebecca Dobra, Jane Davies, Stuart Elborn, et al.
Future Oncology (London, England)|September 28, 2021
CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma: physician preferences trading off benefits, risks and time to infusionMarco Boeri, Anna G Purdum, Jessie Sutphin, et al.
Environmental & Resource Economics|July 18, 2025
A Stated Preference Study to Explore Market-Based Instruments to Reduce Car UsageChristopher Tate, Alberto Longo, Marco Boeri, et al.
Expert Review of Vaccines|September 26, 2022
Travelers' preferences for tick-borne encephalitis vaccinationChristine Poulos, Marco Boeri, Joshua Coulter, et al.
The Journal of Dermatological Treatment|October 7, 2020
Quantifying patient preferences for systemic atopic dermatitis treatments using a discrete-choice experimentMarco Boeri, Jessie Sutphin, Brett Hauber, et al.
BMJ Open|March 3, 2021
Discrete choice experiment (DCE) to quantify the influence of trial features on the decision to participate in cystic fibrosis (CF) clinical trialsRebecca Anne Dobra, Marco Boeri, Stuart Elborn, et al.
Patient Preference and Adherence|August 3, 2019
From drug-delivery device to disease management tool: a study of preferences for enhanced features in next-generation self-injection devicesMarco Boeri, Boglarka Szegvari, Brett Hauber, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 4, 2018
Physician-Specific Maximum Acceptable Risk in Personalized Medicine: Implications for Medical Decision MakingMarco Boeri, Alan J McMichael, Joseph P M Kane, et al.
Pageof 6